BPC-157BPC
Healing & Recovery
Synthetic gastric peptide studied in research for tissue-healing and cytoprotective properties
Not established in human PK data; preclinical data suggest short plasma half-life with local tissue accumulation200–600 mcg
TB-4 (Thymosin β4)TB-4
Healing & Recovery
Full-length thymosin beta-4: 43 amino acids; studied in clinical trials, distinct from the TB-500 fragment.
TB-500TB
Healing & Recovery
Acetylated seven-amino-acid fragment of thymosin beta-4 (Ac-LKKTETQ); distinct from full-length TB-4.
IpamorelinIPA
Growth Hormone
Selective growth hormone secretagogue studied for minimal off-target hormonal effects
1.5–2.5 hours100–250 mcg
CJC-1295 (no DAC)CJC
Growth Hormone
CJC-1295 NO DAC (5 mg Vial) — Dosing Studied in Research
~30 minutes100-300 mcg
GHK-CuGHK
Skin & Anti-Aging
Copper-binding tripeptide studied for skin regeneration, wound healing, and tissue repair
Unknown; research-grade protocols based on empirical use1.0–2.0 mg per injection
SemaglutideSEMA
Metabolic
Once-Weekly GLP-1 Agonist for Weight Management & Glycemic Control
~7 days250–2400 mcg weekly
TirzepatideTIRZ
Metabolic
Dual GLP-1 / GIP Incretin Receptor Agonist for Metabolic & Weight Management
~5 days2.5–15 mg once weekly
RetatrutideRETA
Metabolic
Triple-receptor agonist studied for weight loss and metabolic health
~6 days (once-weekly dosing)2–12 mg weekly
PT-141 (Bremelanotide)PT
Vitality
Central melanocortin agonist studied for sexual desire and arousal
~2.7 hours (bremelanotide)500–1500 mcg
NAD+NAD
Vitality
Studied for cellular energy, DNA repair, and mitochondrial resilience through NAD+ replenishment
Not well established for SC route; IV half-life is short (minutes to a few hours)50–100 mg once daily
5-Amino-1MQ5A1MQ
Metabolic
Selective NNMT inhibitor studied for fat metabolism and NAD+ elevation
Approximately 3.8–6.9 hours2.5–5 mg once or twice daily (subcutaneous)
AdamaxADX
Cognitive & Nootropic
Adamantane-Modified Semax Analog Studied for Cognitive & Neuroprotective Research
Extended vs. standard Semax due to adamantane modification (prolonged in vivo half-life)500–1000 µg daily
AdipotideADP
Metabolic
Vascular-targeted pro-apoptotic peptide investigated in white adipose tissue research
Not established in humans250–1000 mcg daily
AICARAICAR
Metabolic
The "Exercise Pill" — Studied as an AMPK Activator & Metabolic Modulator
Short (hours; specific half-life not established for subcutaneous research dosing)1,000–3,000 mcg daily (conservative); up to 5,000 mcg in advanced protocols
AOD-9604AOD
Metabolic
Synthetic hGH C-terminal fragment studied for lipolysis without IGF-1 elevation
Not established in published literature for subcutaneous dosing300-500 mcg daily
Ara-290 (Cibinetide)ARA
Healing & Recovery
Educational guide to research reconstitution and dosing
Not specified2–4 mg daily
CagrilintideCAGRI
Metabolic
Long-acting amylin analogue studied for once-weekly weight management
Approximately 160–195 hours0.25–2.4 mg weekly
CartalaxCART
Bioregulator
Synthetic tripeptide bioregulator studied for connective tissue and extracellular matrix
Not established in published literature; ultrashort peptides are generally subject to rapid proteolytic degradation2,000–5,000 mcg daily
CerebrolysinCERE
Cognitive & Nootropic
Neurotrophic peptide preparation studied for neuronal survival and neuroprotection
Short; clinical literature supports once- or twice-daily subcutaneous dosing20–32 mg daily
ChonlutenCHON
Bioregulator
Bronchopulmonary bioregulatory tripeptide (Glu-Asp-Gly)
Not established (short peptide; rapid systemic clearance expected)250–4,000 mcg once daily
CJC-1295 DACCJC-DAC
Growth Hormone
Long-acting GHRH analog with albumin-binding DAC technology studied for once-weekly dosing
6–8 days1000–2000 mcg per week
CortagenCORT
Bioregulator
Neuroprotective tetrapeptide bioregulator studied for nerve regeneration and cognition
Not established in published literature1000–2000 mcg daily
Delta Sleep-Inducing PeptideDSIP
Sleep & Recovery
Naturally occurring nonapeptide studied for slow-wave sleep support and stress modulation
Not established in published literature100–500 mcg daily (typical 100–300 mcg; advanced up to 500 mcg)
Epitalon (Epithalon)EPI
Longevity
Synthetic tetrapeptide studied for telomerase activation and geroprotection
Not established in published human pharmacokinetic data5,000 mcg (5 mg) once daily; alternative: 10 mg/day for 10 days (same total 100 mg cycle dose)
FOXO4-DRIFOXO4
Longevity
Senolytic peptide studied for the selective clearance of senescent "zombie" cells
Not established in humans250–500 mcg daily with gradual escalation
GHRP-2GHRP-2
Growth Hormone
GH secretagogue studied for pulsatile release
~15–30 minutes (plasma elimination); GH response peak ~30–60 minutes post subcutaneous injection100–300 mcg daily
GHRP-6GHRP-6
Growth Hormone
GH secretagogue studied for pulsatile release via ghrelin receptor activation
~2.5 hours100–300 mcg per injection
GlutathioneGSH
Skin & Anti-Aging
Antioxidant tripeptide studied for cellular detoxification and redox balance
Short; exact subcutaneous half-life not well established in literature100–200 mg daily
GonadorelinGnRH
Hormonal & Fertility
Synthetic GnRH studied for HPG axis function and fertility research
2–10 minutes (endogenous GnRH); synthetic gonadorelin cleared rapidly after each pulsatile dose50–250 mcg per injection
Human Chorionic GonadotropinHCG
Hormonal & Fertility
LH-mimetic glycoprotein hormone studied for testicular maintenance and fertility research
36 hours500–2500 IU per injection
HGH 191AAHGH
Growth Hormone
Recombinant human growth hormone identical to endogenous GH — studied for body composition, metabolic regulation, and tissue repair.
~20–30 minutes (IV); ~2–4 hours (subcutaneous)150–500 mcg/day (conservative) to 1000–2000 mcg/day (advanced protocols)
Human Menopausal GonadotropinHMG
Hormonal & Fertility
HMG (0.15 mg / 75 IU Vial) — Study-Referenced Dosing Overview
~24-36 hours (FSH component); LH component shorter75-150 IU
IGF-1 LR3IGF
Growth Hormone
Long-acting IGF-1 analog with extended half-life, studied in anabolic and metabolic research
Several hours (extended from minutes for native IGF-1)20–50 mcg
Kisspeptin-10KISS
Hormonal & Fertility
Upstream signal studied in the reproductive hormone cascade
~4 minutes100–200 mcg daily
KPVKPV
Healing & Recovery
C-terminal tripeptide fragment of alpha-MSH studied for anti-inflammatory activity without melanotropic effects
Not established in published human pharmacokinetic studies200–500 mcg daily
L-CarnitineLCAR
Metabolic
Mitochondrial fatty acid transporter studied for fat oxidation and energy production
Not specified on source page; plasma half-life of L-Carnitine is approximately 17 hours50–200 mg/day
LivagenLIV
Bioregulator
Synthetic tetrapeptide bioregulator studied for peptidase inhibition and epigenetic modulation in aging tissues.
Not established; estimated ~30 minutes based on tetrapeptide pharmacokinetic inference (no formal studies published)0.5–2.0 mg daily with gradual titration
LL-37LL-37
Healing & Recovery
Human cathelicidin antimicrobial peptide studied for wound healing and immune modulation
Short; exact subcutaneous half-life not established in peer-reviewed literature — once-daily dosing used in protocols100–400 mcg per day
MazdutideMAZ
Metabolic
Long-acting dual GLP-1/glucagon receptor agonist studied for weight management and metabolic health
Approximately 7 days (once-weekly dosing)2.5–6 mg weekly (advanced protocols may reach 10 mg)
Melanotan IIMT-II
Vitality
Synthetic melanocortin agonist studied for skin pigmentation and sexual function
1–2 hours250–1000 mcg
Mechano Growth FactorMGF
Growth Hormone
IGF-1 Splice Variant Studied for Muscle Repair & Satellite Cell Activation
Approximately 5–7 minutes (unmodified); PEGylated forms have extended half-life of several hours100–300 mcg once daily
MOTS-CMOTS-C
Metabolic
Mitochondrial-derived peptide studied for metabolic homeostasis, insulin sensitivity, and healthy aging
Estimated 1–2 hours based on endogenous exercise-induced levels returning to baseline within 4 hours; formal human pharmacokinetic data not yet established500–2000 mcg per day (titrated; typical maintenance 500–1500 mcg)
OvagenOVA
Bioregulator
Synthetic ultrashort tripeptide bioregulator studied for gastrointestinal and liver tissue support
Not established (ultrashort peptide; rapidly metabolized)10–150 mcg once daily
OxytocinOXT
Vitality
The Social Bonding Peptide — Studied for Trust, Calm & Connection
Short — approximately a few minutes in plasma; central effects may persist longer via receptor binding100–500 mcg
PE-22-28PE
Cognitive & Nootropic
TREK-1 antagonist studied for antidepressant and neuroplasticity effects
~23 hours50–200 µg daily; 100–150 µg commonly considered adequate
PEG MGFPEG-MGF
Growth Hormone
PEGylated Mechano Growth Factor Studied for Muscle Repair and Satellite Cell Activation
Extended (multi-day) due to PEGylation; once-daily dosing supported200–500 mcg once daily
PinealonPIN
Bioregulator
Neuroprotective tripeptide bioregulator studied for cognitive health and brain longevity
Not established in published literature; short peptide half-lives are typical for tripeptides1.0–2.0 mg once daily
PNC-27PNC
Longevity
Synthetic p53-derived peptide studied preclinically for selective cancer-cell cytotoxicity
Not established (no published human pharmacokinetic data)100–500 mcg once daily
ProstamaxPROST
Bioregulator
Prostamax is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Pro / KEDP) derived from prostate tissue peptide complex research.
Not established in published human data500 mcg–1 mg daily with gradual titration
SelankSEL
Cognitive & Nootropic
Selank is a synthetic heptapeptide analog of tuftsin studied for anxiolytic and anti-asthenic (energy-related) properties in human clinical trials.
~2–10 min plasma half-life; pharmacodynamic effects persist 12–24 hours300–500 mcg
SemaxSEM
Cognitive & Nootropic
Neuroprotective heptapeptide analog of ACTH(4–10) studied for cognitive and cerebrovascular research
Short biological half-life; subcutaneous delivery provides more sustained systemic absorption than intranasal dosing200–500 mcg once daily
SermorelinSERM
Growth Hormone
Studied for endogenous GH stimulation via pituitary GHRH activation
~10–20 minutes (active pulsatile GH secretion lasting several hours)200–500 mcg daily
SLU-PP-332SLU
Metabolic
PRECLINICAL RESEARCH COMPOUND: Pan-ERR agonist studied as an exercise mimetic
Unknown — not established in human or preclinical pharmacokinetic studies1250–2500 mcg daily (divided doses, murine-equivalent)
SNAP-8SNAP-8
Skin & Anti-Aging
Topical-grade octapeptide studied for relaxing expression muscles to smooth dynamic wrinkles without paralysis.
Not established (topical/local peptide; systemic half-life data not available)330–1,000 mcg daily
SS-31 (Elamipretide)SS-31
Longevity
Mitochondria-targeted tetrapeptide studied for stabilizing the inner membrane and supporting cellular energy output.
~2–4 hours (based on pharmacokinetic data from clinical studies)5–20 mg/day
SurvodutideSURVO
Metabolic
Dual GLP-1/glucagon receptor agonist studied for obesity and metabolic liver disease
~7 days (once-weekly dosing)0.6–6.0 mg once weekly
TesamorelinTESA
Growth Hormone
FDA-approved GHRH analog studied for visceral fat reduction and metabolic health
~26–38 minutes (endogenous GH pulse duration; IGF-1 elevation sustained over 24 hours)1000–2000 mcg/day
TestagenTEST
Bioregulator
Anterior pituitary tetrapeptide bioregulator studied for endocrine and pituitary–gonadal axis research
Not established in human studies100–300 mcg daily
Thymosin Alpha-1TA1
Immune
Thymic immunomodulator studied for T-cell support and host defense research
~2–3 hours300–500 mcg daily
Vesugen (Lys-Glu-Asp)VES
Bioregulator
Tripeptide vascular bioregulator studied for endothelial cell renewal and Ki-67 gene expression
Not established in published literature; short-chain tripeptides typically have rapid systemic clearance500–2000 mcg once daily
VilonVIL
Bioregulator
Immunoregulatory dipeptide studied for immune cell markers and aging
Not established in published literature67–670 mcg daily
LiraglutideLIRA
Metabolic
Once-Daily GLP-1 Agonist for Weight Management & Glycemic Control
~13 hours0.6–3.0 mg daily
DulaglutideDULA
Metabolic
Once-Weekly GLP-1 Receptor Agonist for Glycemic Control
~5 days750–4500 mcg weekly
ExenatideEXEN
Metabolic
First-in-Class GLP-1 Receptor Agonist Derived from Exendin-4
~2.4 hours (immediate-release)5–10 mcg twice daily
Follistatin-344 (FST-344)FS-344
Longevity
Myostatin- and activin-binding protein studied in research for muscle growth, tissue repair, and preservation of lean mass with age.
Reported values vary by preparation: injectable research peptide is described with a short plasma half-life of roughly 3–4 hours, while native circulating follistatin has been reported around 28 hours in pharmacokinetic literature; no controlled human data exists for the injectable research form100–300 mcg/day
DihexaDHX
Cognitive & Nootropic
Angiotensin IV–derived peptidomimetic studied in preclinical research for HGF/c-Met-driven synaptogenesis
Reported plasma half-life is short to moderate (microsomal metabolic half-life ≈ 509 minutes, ~8.5 hours), with relatively slow systemic clearance noted in animal pharmacokinetic studies; once-daily dosing is used in research protocols1–3 mg once daily
HexarelinHEX
Growth Hormone
Potent synthetic growth hormone secretagogue studied for GH release and direct cardiac (CD36) effects
About 55–90 minutes100–300 mcg
GHRP-1GHRP-1
Growth Hormone
First-generation GH secretagogue studied for pulsatile release
~15–30 minutes (plasma elimination); GH response typically peaks ~30–60 minutes after subcutaneous injection100–300 mcg per injection
TriptorelinGnRH agonist
Hormonal & Fertility
Long-acting GnRH agonist studied for HPG axis suppression, fertility triggering, and hormone-sensitive conditions
Approximately 3 hours terminal elimination half-life for immediate-release triptorelin acetate; subcutaneous absorption prolongs the apparent half-life roughly 10-fold versus intravenous dosing, and depot pamoate/embonate formulations release the peptide over 1–6 months50–200 mcg per dose (0.05–0.2 mg); ~100 mcg daily for down-regulation, ~200 mcg single dose as a trigger
Melanotan IMT-I
Vitality
Highly MC1R-selective α-MSH analog studied for skin pigmentation; its long-acting form (afamelanotide) is an approved EPP therapy
Approximately 30–33 minutes (plasma); melanogenic effects persist ~48–72 hours250–1000 mcg
P21P21
Cognitive & Nootropic
CNTF-derived neurotrophic peptide mimetic studied for neurogenesis and cognitive research
Short plasma half-life reported at roughly 4–6 hours (limited pharmacokinetic data); adamantylation improves metabolic stability and CNS penetration500–1,000 mcg once daily
ThymalinTHY
Bioregulator
Thymus-derived peptide complex studied for immune restoration and healthy aging
Estimated ~3–6 hours (elimination) based on secondary sources; not firmly established in peer-reviewed pharmacokinetic studies5–10 mg daily
VIP (Vasoactive Intestinal Peptide)VIP
Bioregulator
28-amino-acid neuropeptide signaling through VPAC1/VPAC2 receptors
Approximately 1–2 minutes (very short plasma half-life; rapid systemic clearance)50–100 mcg subcutaneously, once or twice daily
EloralintideELO
Metabolic
Amylin receptor agonist being studied in clinical research on appetite and body weight regulation
AbaloparatideABL
Healing & Recovery
Synthetic PTHrP analogue studied in research on bone metabolism and bone density
TeriparatideTERI
Healing & Recovery
Recombinant fragment of parathyroid hormone (1–34) studied in research on bone formation
TB-500 Fragment (17-23)TB-FRAG
Healing & Recovery
Short section of the thymosin beta-4 sequence studied in preclinical models of tissue repair
Ac-SDKP (TB-500 Fragment 1-4)AC-SDKP
Healing & Recovery
Naturally occurring tetrapeptide (thymosin beta-4 fragment 1–4) considered in research on tissue remodelling and fibrosis
N-Acetyl Epitalon AmidateNA-EPI
Longevity
Chemically stabilised variant of the tetrapeptide epitalon considered in research on cellular ageing
N-Acetyl Semax AmidateNA-SEM
Cognitive & Nootropic
Stabilised variant of the peptide semax considered in research on attention and neurotrophic signalling
N-Acetyl Selank AmidateNA-SEL
Cognitive & Nootropic
Stabilised variant of the peptide selank studied in research on anxiety-related behaviour
PTD-DBMPTD
Skin & Anti-Aging
Cell-permeable peptide studied in preclinical models in connection with the Wnt pathway and hair follicles
GHK (Copper-Free)GHK-F
Skin & Anti-Aging
Endogenous tripeptide without a copper complex, considered in research on skin matrix and wound healing
AHK-CuAHK
Skin & Anti-Aging
Copper-bound tripeptide considered in cosmetic research in connection with hair follicles
HumaninHN
Longevity
Mitochondrially encoded peptide studied in research on cellular stress and ageing processes
ThymulinTHN
Immune
Zinc-dependent thymic hormone considered in research on T-lymphocyte maturation
BronchogenBRON
Bioregulator
Synthetic tetrapeptide from Russian bioregulator research, associated with bronchial tissue
CardiogenCARD
Bioregulator
Synthetic tetrapeptide from bioregulator research, associated with heart muscle tissue
PancragenPANC
Bioregulator
Synthetic tetrapeptide from bioregulator research, associated with pancreatic tissue
ThymogenTHYG
Bioregulator
Synthetic dipeptide from bioregulator research, associated with thymus tissue
CrystagenCRYS
Bioregulator
Synthetic tripeptide from bioregulator research, associated with the immune system
MelatoninMEL
Sleep & Recovery
Endogenous hormone of the pineal gland studied in research on sleep-wake rhythm regulation
Matrixyl (Palmitoyl Pentapeptide-4)MTX
Skin & Anti-Aging
Cosmetic signal peptide considered in skin research in connection with collagen synthesis
Vitamin B12 (Cyanocobalamin)B12
Vitality
Water-soluble vitamin (cobalamin) essential for blood formation and nerve function